KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Buildings (2016 - 2025)

Merck (MRK) has disclosed Buildings for 17 consecutive years, with $18.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Buildings rose 9.92% to $18.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $18.0 billion, a 9.92% increase, with the full-year FY2025 number at $18.0 billion, up 9.92% from a year prior.
  • Buildings was $18.0 billion for Q4 2025 at Merck, up from $16.4 billion in the prior quarter.
  • In the past five years, Buildings ranged from a high of $18.0 billion in Q4 2025 to a low of $12.5 billion in Q4 2021.
  • A 5-year average of $15.0 billion and a median of $15.0 billion in 2023 define the central range for Buildings.
  • Peak YoY movement for Buildings: increased 4.43% in 2021, then increased 13.67% in 2023.
  • Merck's Buildings stood at $12.5 billion in 2021, then rose by 5.08% to $13.2 billion in 2022, then grew by 13.67% to $15.0 billion in 2023, then grew by 9.31% to $16.4 billion in 2024, then grew by 9.92% to $18.0 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Buildings are $18.0 billion (Q4 2025), $16.4 billion (Q4 2024), and $15.0 billion (Q4 2023).